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ABSTRACT  
Aim: To analyze the behavior of B-type natriuretic peptide (BNP) in the presence of defining 
characteristics (DCs) of the nursing diagnosis Excess fluid volume (00026) in patients 
hospitalized for acute decompensated heart failure.  
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Methods: Cohort study of patients admitted with acute decompensated heart failure 
(September 2015 to September 2016) defined by Boston Criteria.  Patients hospitalized for up 
to 36 h with BNP values ≥ 100 pg/ml were included; BNP values at baseline-final assessment 
were compared by Wilcoxon test, the number of DCs at baseline-final assessment was 
compared by paired t-test.  
Results: Sixty-four patients were included; there was a significant positive correlation 
between delta of BNP and the number of DCs present at initial clinical assessment. 
Conclusions: The behavior of BNP was correlated to the DCs indicating congestion. With 
clinical compensation, DCs and BNP decreased. The use of this biomarker may provide 
additional precision to the nursing assessment. 
Keywords: Heart failure. Nursing diagnosis. Biomarkers. Nursing. Cardiology. Signs and 
symptoms.    
 
RESUMO 
Objetivo: Analisar o comportamento do peptídeo natriurético tipo B (BNP) na presença de 
características definidoras (CDs) do diagnóstico de enfermagem Excesso de volume de 
líquidos (00026) em pacientes hospitalizados por insuficiência cardíaca descompensada. 
Métodos: Estudo de coorte com pacientes internados com insuficiência cardíaca 
descompensada (setembro-2015 a setembro-2016), definida pelos Critérios de Boston. 
Pacientes hospitalizados por mais de 36 horas, valor de BNP ≥ 100 pg/ml foram incluídos; 
valores de BNP basal-final foram comparados pelo teste Wilcoxon; as CDs no basal-final 
foram comparadas pelo teste t pareado.  
Resultados: Sessenta e quatro pacientes foram incluídos; houve correlação positiva 
significativa entre o delta de BNP com o número de CDs presentes na avaliação clínica 
inicial.  
Conclusões: O comportamento do BNP foi correlacionado com as CDs, indicando congestão. 
Com a compensação clínica, as CDs e a concentração de BNP diminuíram. O uso deste 
biomarcador pode fornecer precisão adicional à avaliação de enfermagem. 
 Palavras-chave: Insuficiência cardíaca. Diagnóstico de enfermagem. Biomarcadores. 
Enfermagem. Cardiologia. Sinais e sintomas. 
 
RESUMEN 
Objetivo: Analizar el comportamiento del péptido natriurético tipo B (BNP) en presencia de 
características definitorias (CD) del diagnóstico de enfermería Exceso de volumen de líquidos 
(00026) en pacientes hospitalizados por insuficiencia cardíaca aguda descompensada (ICAD). 
Métodos: Estudio de cohorte de pacientes ingresados con ICAD (septiembre/2015 a 
septiembre/2016).Se incluyeron pacientes hospitalizados hasta 36 h con valores de BNP ≥ 100 
pg / ml; Los valores de BNP en la evaluación inicial basal se compararon mediante la prueba 
de Wilcoxon, el número de CD en la evaluación inicial basal se comparó mediante el Test-T 
apareado.  
Resultados: Se incluyeron 64 pacientes; hubo una correlación positiva significativa entre el 
delta del BNP y las CD presentes en la evaluación clínica inicial.  
Conclusiones: El comportamiento del BNP se correlacionó con las CD que indican 
congestión. Con compensación clínica, las CD y el BNP disminuyeron. El uso del BNP puede 
proporcionar precisión adicional a la evaluación de enfermería. 
Palabras clave: Insuficiencia cardíaca. Diagnóstico de enfermería. Biomarcadores 
Enfermería. Cardiología. Signos y síntomas. 
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INTRODUCTION 
In Brazil, acute decompensated heart failure (ADHF) accounts for a substantial portion of 
hospital admissions(1). Heart failure (HF) itself is one of the leading causes of morbidity and 
mortality worldwide, affecting 26 million people in the last five years(2-3), 15 million in 
Europe alone(3-4) . 
Clinical congestion, composed of dyspnea, edema, hepatojugular reflux, and jugular 
venous distension, is the most common manifestation in patients admitted to emergency 
services for ADHF(5-6). Studies conducted at emergency departments and HF clinics, where 
patients often present with these signs and symptoms, indicate that the nursing diagnosis (ND) 
“Excess fluid volume” is often established(7-8). These findings were validated in a study of 
patients with decompensated HF in an emergency setting, indicating that these clinical 
manifestations are indeed present in the clinical examination performed by nurses(5). Although 
the ND “Excess fluid volume” (EFV) is accurate for congested patients, it has been suggested 
by nurses that these signs and symptoms can also reflect conditions of the respiratory system, 
thus compromising diagnostic accuracy(7).  
Recently, a report on the state of the art of early treatment of ADHF demonstrated that 
medical team decisions upon arrival at the emergency department have a direct impact on 
morbidity and mortality. The authors showed that 80% of patients with ADHF presented with 
defining characteristics of congestion, including presence of third heart sound, dyspnea, 
orthopnea, positive hepatojugular reflex, jugular vein distension, edema, and paroxysmal 
nocturnal dyspnea. In this study, the importance of biomarkers – especially B-type natriuretic 
peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) – was emphasized 
because they helped improve diagnostic accuracy and speed(6). 
Given the importance of establishing a precise diagnosis so that nursing interventions are 
effective and good patient outcomes are achieved, the possibility of incorporating into the 
nursing process tools that could corroborate diagnostic accuracy at the bedside must be 
considered. An accurate diagnosis reflects the patient's real state because it is found through 
the knowledge and history of the patient, allowing the nurse to plan strategies that have a 
better prediction capacity for a given diagnosis(11). In the specific case of EFV, one biomarker 
in particular has been widely studied in the last two decades: BNP, which can be used to 
distinguish cardiac dyspnea from pulmonary dyspnea(5,9-10).  
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To improve the accuracy of diagnosis, ND should be based not only on patients’ 
clinical parameters, but also on laboratory and imaging findings(11-12). In this perspective, we 
understand that the use of biomarkers, such as BNP, can corroborate diagnostic accuracy in 
the clinical assessment of patients with congestive HF(3,13). 
 Within this context, this study was designed to analyze the behavior of B-type 
natriuretic peptide in the presence of defining characteristics of the nursing diagnosis Excess 
fluid volume (00026) in patients hospitalized for acute decompensated heart failure. Our 
hypothesis was that BNP level might be added as a new defining characteristics (DC) to this 
ND.  
 
METHODS 
This was a cohort study with prospective data collection, developed in a master 
dissertation entitled Behavior of the B-type natriuretic peptide marker and its relation to the 
nursing diagnosis Excess Fluid Volume in patients hospitalized for decompensated heart 
failure. These patients were included in an emergency department and inpatient units of a 
public, university-affiliated hospital in Southern Brazil. The data collection period lasted 
approximately 12 months (from September 2015 to September 2016). 
Inclusion criteria were adult patients with systolic HF or HF with preserved ejection 
fraction (HFpEF) with a diagnosis of ADHF who met the Boston Criteria with a score of 8 or 
higher(14). These criteria include patient history, physical examination findings, crackles, and 
chest X-ray findings. Each category carries a maximum score of 4 points (item score of the 
highest category value). The diagnosis of ADHF can be classified as “definitive” (8 to 12 
points), “likely” (5 to 7 points), or “unlikely” (4 points or less)(14).  
Besides the Boston criteria, patients hospitalized for up to 36 h with BNP values ≥ 100 
pg/ml were included; those with infectious conditions, obesity and impaired renal function 
were excluded due to potential impact of these factors on BNP levels. 
After daily screening, the team, which was composed of HF nurses and nursing 
students trained for this stage, invited patients to participate in the study. Those who agreed 
and signed an informed consent form were assessed for eligibility by the Boston Criteria(14). 
After clinical assessment, a 3-ml sample of blood was collected for BNP measurement. 
Clinical assessment and blood collection occurred within 36 h of hospital admission and were 
repeated at final patient assessment (at discharge or 7 days after study inclusion, whichever 
came first). Clinical data – New York Heart Association (NYHA) classification(15), HF 
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etiology, comorbidities, left ventricular ejection fraction, and current medications – and 
sociodemographic characteristics were also collected by a researcher, nurse specialist in 
cardiology. Additional data were obtained from patients’ medical records when unavailable at 
the time of interview.  
The sample size, estimated on the basis of a 0.4 correlation between BNP levels and 
the number of DCs present at clinical assessment, with a 5% significance level and 80% 
statistical power, was calculated as 47 patients at least. 
Pursuant to a previous clinical validation study conducted by nurse specialists in 
cardiology to test for the presence of the primary defining characteristics (dyspnea, orthopnea, 
edema, positive hepatojugular reflex, paroxysmal nocturnal dyspnea, pulmonary congestion, 
and increase in central venous pressure) and secondary defining characteristics (weight gain, 
hepatomegaly, jugular vein distension, crackles, oliguria, low hemoglobin count, and anemia) 
of ND Excess fluid volum(5). These are described below as listed in the NANDA-International 
(NANDA-I) classification(11), as well as their definitions and the new DCs validated and 
included in the 2015-2017 edition of NANDA-I: hepatomegaly and paroxysmal nocturnal 
dyspnea(5,11).  
BNP values were obtained from laboratory records after each patient’s final 
assessment. The reference range for BNP is <100 pg/ml for patients not diagnosed with 
ADHF and > 400-500 pg/ml for patients with confirmed ADHF(3,12). BNP levels were 
checked by the team at the end of patient follow-up to avoid a selection bias. 
Statistical analyses were carried out in SPSS version 20.0. The Shapiro-Wilk test was 
used to test for normality of data distribution. Continuous variables were expressed as mean 
and standard deviation or median and interquartile range as appropriate. Categorical variables 
were expressed as absolute and relative frequencies. Spearman’s rank correlation coefficients 
were used to calculate the relationship between the number of primary and secondary DCs of 
Excess fluid volume and the delta-BNP (variation of BNP´s values). BNP values at baseline 
and at final assessment were compared using the Wilcoxon signed-rank test, while the number 
of DCs present at baseline vs. at final assessment was compared through a paired t-test. A p- 
value < 0.05 was considered statistically significant. 
The study was approved by the institutional Research Ethics Committee under number 
150.362 (CAAE: 47661315200005327). 
 
RESULTS 
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We evaluated 64 adults. The patients were predominantly elderly (age 69 ± 13 years) 
and male (n=34, 53%). Mean LVEF was 50 ± 16%. The most common HF etiologies were 
hypertension (39%) and ischemic heart disease (36%). Patient weight declined during the 
hospitalization period (78 ± 20 kg at admission vs.  75 ± 20 at final assessment), as did the 
Boston score (10 [8-11] at admission vs. 5.5 [4-7] at final assessment). The median length of 
stay was 7 (4-17) days, and hypertension was the most prevalent comorbidity (81%). 
There was a moderate and significant positive correlation between delta-BNP٭ and the 
number of DCs of Excess fluid volume present at baseline clinical assessment (r = 0.304, p = 
0.018). Figure1. 
 
 
Figure 1 - Correlation between delta-BNP and the 15 defining characteristics of the nursing 
diagnosis Excess fluid volume (00026) at admission and at final patient assessment.  
Source: Research data, 2017. 
Spearman’s rank correlation, p = 0.018.  
٭ B-type natriuretic peptid 
 
Median BNP٭ values reduced significantly from baseline to final assessment (381 
[202-707] pg/ml vs. 309 [180-640] pg/ml respectively, p = 0.012).Figure 2. 
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Figure 2 - Median BNP٭ values at admission and final assessment 
                               Source: Research data, 2017. 
                  * B-type natriuretic peptide , † Wilcoxon’s test, p = 0.012. 
 
The figure 3 shows the frequencies of the primary and secondary DCs of the nursing 
diagnosis Excess fluid volume at baseline and at final patient assessment. The decline in 
frequency observed for most DCs is consistent with improvement of congestion over the 
course of hospitalization.  
In a quantitative analysis of the DCs of Excess fluid volume, a reduction in the number 
of DCs present over the course of hospitalization was also observed, from 11 ± 3 at admission 
to 7.5 ± 3 at final assessment (p < 0.001).Figure 3. 
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Figure 3 – Relative frequency of patients with (a) primary and (b) secondary defining 
characteristics of the nursing diagnosis Excess fluid volume at admission and at final patient 
assessment.  
Source: Research data, 2017. 
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DISCUSSION 
This was the first study conducted in a real-world clinical setting to analyze the 
behavior of BNP levels in peripheral blood and their relationship with the nursing diagnosis 
Excess fluid volume in patients with ADHF. Our findings demonstrate that, during the course 
of hospitalization and treatment for ADHF, as well as a reduction in the number of DCs that 
indicate systemic venous congestion, this biomarker – indicative of high pressures – also 
decreased in peripheral blood as the patients became less congested. The correlation between 
the delta-BNP and the number of DCs of Excess fluid volume present at initial clinical 
assessment was positive, moderate, and significant. Similarly, quantitative evaluation of DC 
and BNP showed a significant reduction from baseline to final assessment.  
The DCs of the diagnosis Excess fluid volume have been clinically validated in 
patients admitted for ADHF, i.e., the same population studied in this study(5). Evidence has 
shown that these DCs are actually indicative of systemic venous congestion, and that their 
presence denotes heavily decompensated HF due to congestive conditions(3,6). 
High BNP values also made the ND Excess fluid volume more accurate in this sample 
and can confirm the diagnosis of  Clinical improvement, indicated by the reduction in BNP 
values from baseline to final assessment, indicates the importance of clinical evaluation by 
nurses. Initial assessment of patients with ADHF in the emergency department plays a 
decisive role in treatment(13,16). Several studies have noted the importance of combining 
bedside clinical assessment with BNP measurements(9,13).  
 The results of the present study confirm that nurses can use non-clinical parameters to 
improve their diagnostic accuracy in patients with HF. Such improvement of diagnostic 
accuracy allows optimization of nursing interventions, especially in emergency-room 
settings(3,9-10,17).  
A previous study confirmed the importance of clinical assessment performed by 
nurses, even outside the emergency setting. Clinical assessment of patients with HF 
performed by specialist nurses was compared to evaluation by cardiologists, and the 
correlation of both assessments with BNP levels was analyzed. The authors found that the 
congestion assessments performed by nurses were similar to those performed by cardiologists, 
and that both correlated highly with BNP values(8). In the present investigation, we found a 
moderate, significant correlation between presence of DCs and BNP values, suggesting that 
congestion of cardiac etiology was indeed present in patients assigned the ND Excess fluid 
volume. 
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The behavior of BNP levels in relation to the presence of DCs of Excess fluid volume 
(i.e., clinical markers of congestion) has also been confirmed by previous studies, as has the 
decrease in BNP at discharge in patients who achieve clinical compensation. In a database 
study of 113 patients with ADHF who achieved compensation (defined as improvement to 
NYHA class I or II) during hospitalization, BNP levels decreased from 917 pg/ml at 
admission to 351 pg/ml after treatment. The authors concluded that BNP levels not only 
reflect the severity of HF and the likelihood of cardiovascular events, but also are 
representative of better clinical condition(16). Besides the reduction of BNP values which is 
observed after clinical compensation of congestion, the values measured at discharge have 
also been a concern of researchers in clinical practice(16). In a study conducted in Italy, BNP 
values decreased from admission to discharge, and the authors concluded that BNP was an 
independent predictor for 6-month all-cause mortality(18). In addition to the usefulness of BNP 
for physical examination and degree of congestion of patients, this is also useful for 
completing the patient's prognosis. In this sense, the nurse has an important role in planning 
the care plan. Thus, in addition to using this biomarker, nurses can use other key clinical 
covariates, including worse NYHA, presence of rales and wider QRS duration(10,16). 
In the present study, sensitivity and specificity analyses were also performed among 
the diagnoses established by staff nurses and baseline BNP values. Sensitivity testing revealed 
that a many nurses established a correct diagnosis when the BNP cutoff value is 413 pg/ml. 
This indicates that patients with BNP values between 400 and 500 pg/ml are indeed 
presenting with ADHF, and that non-cardiac causes of congestion can be ruled out(19).  
Clinical decision-making involves many factors, including experience, understanding 
scientific evidence, and the patient’s profile. The use of BNP for diagnosis, treatment and 
prognosis is already being included in national and international guidelines(1,3).  
The findings of the present study regarding BNP behavior and the state of congestion, 
as indicated by the DCs of Excess fluid volume, show that nurses should consider this 
biomarker in the different clinical practice scenarios of patients with ADHF. The 
identification of signs and symptoms of decompensation is essential for decision-making, and 
clinical examination is paramount. Nevertheless, clinical practice nurses should be familiar 
with other parameters that may improve diagnostic accuracy. 
Limitations  
One limitation of the study was that the patients were discharged in less than 24 hours, 
so the final evaluation and collection of the last BNP was not possible. 
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CONCLUSION 
We conclude that, in patients hospitalized for ADHF, the behavior of BNP in 
peripheral blood paralleled the DCs of Excess fluid volume that indicate clinical congestion; 
as clinical compensation was achieved, both the frequency and number of DCs and the 
concentration of BNP decreased.  
Clinical Implications 
Our findings demonstrate the importance of adding BNP levels to the NANDA-I 
classification as a DC of the diagnosis Excess fluid volume. Use of this biomarker can add 
accuracy to the clinical assessment of patients suspected of having this diagnosis. Accurate 
diagnosis, in turn, facilitates the achievement of favorable patient outcomes. 
This study demonstrated the feasibility of BNP as another parameter that can be added 
to practice in order to improve the diagnostic accuracy in patients with HF. The teaching of 
clinical evaluation should value other parameters that may improve nurses' ability to 
diagnose. Studies in practice scenarios approximate the translation of knowledge immediately 
at the end of the research. 
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